Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical SE: Release of a capital market information

03/11/2019 | 05:25am EDT

DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback
CompuGroup Medical SE: Release of a capital market information

11.03.2019 / 11:23
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 12th Interim Announcement

CompuGroup Medical SE / Share Buyback

Koblenz, March 11 2019

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 12th Interim Announcement

In the period from March 4, 2019, up to and including March 8, 2019, CompuGroup Medical SE has bought back a total of 41,759 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of December 14, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on December 17, 2018.

The overall volume of the shares bought back daily in the period from March 4, 2019, up to and including March 8, 2019, and the daily volume-weighted average stock market prices of the shares are as follows:

Date Overall volume of Volume-weighted average stock
shares bought back market price
(number) (EUR, excluding ancillary
costs of purchase, rounded to
four places according to
commercial practice)
March 4, 2019 14,589 52.4651
March 5, 2019 5,901 52.4814
March 6, 2019 3,834 52.8970
March 7, 2019 9,419 52.2675
March 8, 2019 8,016 51.0778
In total: 41,759 52.1962

The total number of shares which have been bought back so far by CompuGroup Medical SE since December 17, 2018, up to and including March 8, 2019, within the framework of the share buyback program thus amounts to 373,459 no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading).

Koblenz, March 11, 2019

The Management Board

CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany
T: 49 (0) 261 8000-6200
F: 49 (0) 261 8000-3200



11.03.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

 
End of News DGAP News Service

785939  11.03.2019 

fncls.ssp?fn=show_t_gif&application_id=785939&application_name=news&site_id=zonebourse

ę EQS 2019
All news about COMPUGROUP MEDICAL SOCIETAS EUROPAEA
09/21COMPUGROUP MEDICAL SE & CO. KGAA : Preliminary announcement of the publication of quarterl..
EQ
09/20COMPUGROUP MEDICAL : Deutsche Bank remains its Buy rating
MD
09/16COMPUGROUP MEDICAL : Warburg Research revises his opinion and turns to Neutral
MD
09/15COMPUGROUP MEDICAL : Receives a Sell rating from Baader Bank
MD
09/15COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
MD
09/15COMPUGROUP MEDICAL : Gets a Sell rating from Baader Bank
MD
09/14COMPUGROUP MEDICAL : Receives a Buy rating from Jefferies
MD
09/14COMPUGROUP MEDICAL : áMedicaláannounces medium-termátargets foráEBITDA-margináfor the firs..
PU
09/14COMPUGROUP MEDICAL : announces medium-term targets for EBITDA-margin for the first time an..
EQ
09/14PRESS RELEASE : CompuGroup Medical announces medium-term targets for EBITDA-margin for the..
DJ
More news
Analyst Recommendations on COMPUGROUP MEDICAL SOCIETAS EUROPAEA
More recommendations
Financials
Sales 2021 1 022 M 1 198 M 1 198 M
Net income 2021 81,8 M 95,9 M 95,9 M
Net Debt 2021 504 M 590 M 590 M
P/E ratio 2021 49,7x
Yield 2021 0,75%
Capitalization 3 989 M 4 671 M 4 676 M
EV / Sales 2021 4,40x
EV / Sales 2022 4,08x
Nbr of Employees 8 030
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | COP | DE0005437305 | MarketScreener
Technical analysis trends COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 75,65 €
Average target price 84,30 €
Spread / Average Target 11,4%
EPS Revisions
Managers and Directors
Dirk W÷ssner Chairman-Management Board & CEO
Michael Rauch Chief Financial Officer
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas MŘller Vice Chairman & Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA-3.75%4 671
ORACLE CORPORATION38.23%245 868
SAP SE13.08%167 462
INTUIT INC.52.00%157 825
SERVICENOW, INC.21.05%132 019
DOCUSIGN, INC.22.52%53 580